These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23870199)

  • 1. Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells.
    Qiu DZ; Zhang ZJ; Wu WZ; Yang YK
    BMC Complement Altern Med; 2013 Jul; 13():185. PubMed ID: 23870199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice.
    Zhang ZJ; Yang YK; Wu WZ
    J Transl Med; 2014 Feb; 12():57. PubMed ID: 24581171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase.
    Yu Z; Feng H; Sun X; Zhuo Y; Li M; Zhou Z; Huang L; Jiang Y; Zhu X; Zhang X; Le F; Zheng C; Cheng AS; Gao Y
    Sci Rep; 2018 Mar; 8(1):3891. PubMed ID: 29497076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Gai JQ; Sheng X; Qin JM; Sun K; Zhao W; Ni L
    Int J Oncol; 2016 Jan; 48(1):338-48. PubMed ID: 26648168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways.
    Chen YY; Lu HF; Hsu SC; Kuo CL; Chang SJ; Lin JJ; Wu PP; Liu JY; Lee CH; Chung JG; Chang JB
    Environ Toxicol; 2015 Jan; 30(1):74-82. PubMed ID: 23949904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin.
    Sheng X; Zhu P; Zhao Y; Zhang J; Li H; Zhao H; Qin J
    Recent Pat Anticancer Drug Discov; 2021; 16(1):54-65. PubMed ID: 33530915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
    Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
    Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
    Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG
    Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro.
    Huang AC; Yang MD; Hsiao YT; Lin TS; Ma YS; Peng SF; Hsia TC; Cheng YD; Kuo CL; Chung JG
    J Ethnopharmacol; 2016 Dec; 194():1043-1050. PubMed ID: 27833027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling.
    Zhang X; Lu X; Shi J; Li Y; Li Y; Tao R; Huang L; Tang Y; Zhu X; Li M; Gao Y; Feng H; Yu Z
    Phytomedicine; 2024 Apr; 126():155395. PubMed ID: 38340578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of CD44 inhibits proliferation, migration, and invasiveness in hepatocellular carcinoma cells by modulating CXCR4/Wnt/β-Catenin Axis.
    Song X; Ding F; Luo W; Tao J; Yang K; Li Q; Zhang Z
    Acta Biochim Pol; 2023 Feb; 70(1):117-122. PubMed ID: 36735564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.
    Wu SH; Hsiao YT; Kuo CL; Yu FS; Hsu SC; Wu PP; Chen JC; Hsia TC; Liu HC; Hsu WH; Chung JG
    Am J Chin Med; 2015; 43(6):1247-64. PubMed ID: 26446205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
    Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
    Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway.
    Zhang Y; Wang CP; Ding XX; Wang N; Ma F; Jiang JH; Wang QD; Chang JB
    Asian Pac J Cancer Prev; 2014; 15(16):6829-35. PubMed ID: 25169533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
    Chen K; Zhang S; Ji Y; Li J; An P; Ren H; Liang R; Yang J; Li Z
    PLoS One; 2013; 8(9):e72927. PubMed ID: 24039823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
    Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
    Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
    Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
    Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.